Olr208 inhibitors represent a specialized class of chemical compounds designed to modulate the activity of the Olr208 receptor, a member of the olfactory receptor family. These receptors, primarily located in the olfactory epithelium, are G-protein-coupled receptors (GPCRs) that play a critical role in detecting volatile chemical compounds, thereby contributing to the sense of smell. The structure of Olr208, like other olfactory receptors, comprises seven transmembrane helices that span the cell membrane, allowing the receptor to interact with various ligands. Olr208 inhibitors are developed to bind to this receptor, altering its conformation and preventing the typical signaling cascade that occurs upon ligand binding. By inhibiting the receptor's function, these compounds provide valuable insights into the receptor's role in olfactory signaling pathways and contribute to understanding the broader mechanisms by which olfactory receptors influence sensory perception and signal transduction.
The study of Olr208 inhibitors also extends into the realm of molecular biology, where these inhibitors serve as tools for dissecting the intricate signaling networks associated with GPCRs. The specificity of these inhibitors toward the Olr208 receptor allows researchers to pinpoint the precise interactions and downstream effects that occur when this receptor is either activated or suppressed. This specificity is crucial for mapping out the signaling pathways and understanding how different olfactory receptors contribute to complex sensory processing. Furthermore, the development of Olr208 inhibitors involves a deep exploration of receptor-ligand interactions, utilizing computational modeling, structure-activity relationship studies, and advanced biochemical techniques. These efforts not only enhance the understanding of the Olr208 receptor's role within the olfactory system but also contribute to the broader field of GPCR research, shedding light on the molecular dynamics and functional diversity of these receptors across different biological contexts.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
(RS)-Atenolol | 29122-68-7 | sc-204895 sc-204895A | 1 g 10 g | $79.00 $416.00 | 1 | |
Selective beta1-blocker, can affect cardiovascular signaling pathways, impacting Olr208. | ||||||
Bicalutamide | 90357-06-5 | sc-202976 sc-202976A | 100 mg 500 mg | $42.00 $146.00 | 27 | |
Non-steroidal anti-androgen, may influence hormone-related pathways, affecting Olr208. | ||||||
Cimetidine | 51481-61-9 | sc-202996 sc-202996A | 5 g 10 g | $62.00 $86.00 | 1 | |
H2 receptor antagonist, can alter gastric acid secretion, potentially impacting Olr208. | ||||||
Ezetimibe | 163222-33-1 | sc-205690 sc-205690A | 25 mg 100 mg | $96.00 $241.00 | 12 | |
Cholesterol absorption inhibitor, may influence lipid metabolism, affecting Olr208. | ||||||
Furosemide | 54-31-9 | sc-203961 | 50 mg | $41.00 | ||
Loop diuretic, can impact renal function and electrolyte balance, affecting Olr208. | ||||||
(R)-Cetirizine Dihydrochloride | 130018-77-8 | sc-212682 | 10 mg | $300.00 | ||
Antihistamine, may impact histamine pathways, affecting Olr208. | ||||||
Nebivolol | 99200-09-6 | sc-279910 | 100 mg | $803.00 | 1 | |
Beta-blocker with nitric oxide-potentiating effects, can influence cardiovascular function, impacting Olr208. | ||||||
Omeprazole | 73590-58-6 | sc-202265 | 50 mg | $67.00 | 4 | |
Proton pump inhibitor, can affect gastric acid secretion, potentially impacting Olr208. | ||||||
Rosuvastatin | 287714-41-4 | sc-481834 | 10 mg | $145.00 | 8 | |
Statin, may influence cholesterol biosynthesis, affecting Olr208. | ||||||
Telmisartan | 144701-48-4 | sc-204907 sc-204907A | 50 mg 100 mg | $72.00 $94.00 | 8 | |
Angiotensin receptor blocker, can modulate cardiovascular pathways, impacting Olr208. | ||||||